Intuitive Surgical announced a narrowed growth outlook for its da Vinci surgical system for 2026 and reported a $450 million charge impacting Q3 adjusted earnings. This news led to a stock decline, despite revenue exceeding analyst expectations, as investors focused on the revised projections and the significant one-time charge.
Intuitive Surgical's stock declined after the company adjusted its 2026 growth outlook for its flagship da Vinci surgical system and disclosed a $450 million charge affecting its third-quarter adjusted earnings. This is significant because growth projections are a key driver of valuation for high-growth medical device companies, and a large one-time charge directly impacts profitability. While revenue beat expectations, the market prioritized the forward-looking guidance and the earnings hit. This creates short-term negative pressure on ISRG as investors re-evaluate future growth potential, but could present a long-term opportunity if the charge is truly one-off and the underlying business remains strong.